Pages that link to "Q40359911"
Jump to navigation
Jump to search
The following pages link to Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis (Q40359911):
Displaying 50 items.
- Strategies for early detection of resectable pancreatic cancer (Q24564006) (← links)
- GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective (Q26798142) (← links)
- Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. (Q26827810) (← links)
- GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia (Q28550541) (← links)
- Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies (Q31049380) (← links)
- Genomic profiling of tumor initiating prostatospheres (Q33586722) (← links)
- The anorectic actions of the TGFβ cytokine MIC-1/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract (Q33817236) (← links)
- Growth differentiation factor 15 in erythroid health and disease (Q33908936) (← links)
- Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma (Q34045939) (← links)
- Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality (Q34072831) (← links)
- Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer (Q34099900) (← links)
- Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice (Q34405669) (← links)
- Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer (Q35006757) (← links)
- Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy (Q35051499) (← links)
- Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer (Q35325174) (← links)
- The relationship of serum macrophage inhibitory cytokine-1 levels with gray matter volumes in community-dwelling older individuals. (Q35388790) (← links)
- MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma (Q35475302) (← links)
- Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone mice (Q35563909) (← links)
- Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma (Q35634311) (← links)
- Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI. (Q35711126) (← links)
- Identifying molecular markers for the early detection of pancreatic neoplasia (Q36328508) (← links)
- Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15. (Q36421073) (← links)
- Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women (Q36446724) (← links)
- Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer (Q36570789) (← links)
- The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer (Q36592451) (← links)
- TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator (Q36647686) (← links)
- Development of animal models underlining mechanistic connections between prostate inflammation and cancer (Q36718905) (← links)
- Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1. (Q36746688) (← links)
- Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer (Q37117179) (← links)
- Advances in pancreatic cancer detection (Q37790673) (← links)
- Growth/differentiation factor-15: prostate cancer suppressor or promoter? (Q37988746) (← links)
- Cytokines as potential tumour markers. (Q38089767) (← links)
- Biomarkers in the diagnosis and early detection of pancreatic cancer (Q38089821) (← links)
- The role of inflammation in prostate cancer (Q38211077) (← links)
- Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15. (Q38653870) (← links)
- Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia. (Q38751466) (← links)
- The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. (Q39492314) (← links)
- Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer (Q41002538) (← links)
- Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate (Q43125020) (← links)
- Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer? (Q43690125) (← links)
- Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation (Q47129121) (← links)
- Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity (Q48574810) (← links)
- Further Evidence of Accelerated Aging in Bipolar Disorder: Focus on GDF-15. (Q53420692) (← links)
- Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer. (Q55284651) (← links)
- A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup (Q57167377) (← links)
- Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration (Q60620984) (← links)
- Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer (Q61817355) (← links)
- Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer (Q84204747) (← links)
- Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer (Q84472567) (← links)
- Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion (Q91521072) (← links)